Molecular Basis of PCOS in Oocytes and Surrounding Cells
Launched by UNIVERSITAIR ZIEKENHUIS BRUSSEL · Jul 27, 2020
Trial Information
Current as of May 13, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women between the ages of 18 and 37
- • biochemical hyperandrogenism
- • ovulatory dysfunction
- • polycystic ovaries)
- • BMI \> 25.
- • normal andro-gen levels
- • normal ovarian function
- • normal ovarian morphology
- • BMI \< 29.
- Exclusion Criteria:
- • congenital adrenal hyperplasia
- • Cushing's syndrome
- • androgenic-secreting tumor
- • high (\>grade 2) grade endometriosis
- • major uterine or ovarian abnormalities
- • pregnant women
- • volunteers with metabolic syndrome
About Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel) is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution affiliated with the Vrije Universiteit Brussel, UZ Brussel integrates cutting-edge medical research with high-quality patient care. The hospital's multidisciplinary teams are dedicated to exploring novel therapeutic approaches and contributing to the development of evidence-based treatments, ensuring the highest standards of safety and efficacy in clinical research. With a strong focus on collaboration and knowledge dissemination, UZ Brussel plays a pivotal role in shaping the future of medicine and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials